AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19621718 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 at 12 million IU/day for 3 days before surgery (Group B)
Number of subjects: 31
Study 19621718 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone (Group C)
Number of subjects: 31
Study 16439428 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol (acute administration)
Number of subjects: 18
Study 16439428 — intervention group
Group type: COMPARATOR
Intervention: Older subjects
Number of subjects: 18
Study 16439428 — intervention group
Group type: COMPARATOR
Intervention: Young subjects
Number of subjects: 18
Study 16439428 — intervention group
Group type: EXPERIMENTAL
Intervention: Older and young subjects
Number of subjects: 18
Study 15369615 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy and isoflavone intakes measured by FFQ
Number of subjects: 1823
Study 15369615 — intervention group
Group type: EXPERIMENTAL
Intervention: FFQ assessment of soy food consumption
Number of subjects: 1823
Study 15369615 — intervention group
Group type: COMPARATOR
Intervention: Stratified analyses in case and control groups
Number of subjects: 1823
Study 11519480 — intervention group
Group type: EXPERIMENTAL
Intervention: JC virus type 2 detected in CSF samples
Number of subjects: 52
Study 11519480 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual infection with JC virus types 1 and 2
Number of subjects: 52
Study 11519480 — intervention group
Group type: EXPERIMENTAL
Intervention: JC virus DNA detection in CSF
Number of subjects: 52
Study 11519480 — intervention group
Group type: COMPARATOR
Intervention: JC virus DNA detection in PBMCs and urine
Number of subjects: 52
Study 9266781 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 87
Study 9266781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 7670422 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal bruxers who reported pain
Number of subjects: 80
Study 7670422 — intervention group
Group type: COMPARATOR
Intervention: Myofascial pain patients
Number of subjects: 80
Study 7670422 — intervention group
Group type: EXPERIMENTAL
Intervention: Bruxers
Number of subjects: 80
Study 7670422 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial pain
Number of subjects: 80
Study 2851654 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 16
Study 2851654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium restriction
Number of subjects: 16
Study 2851654 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of low sodium intake and enalapril
Number of subjects: 16
Study 2851654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31621255 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-ankle needle combined with opioid drugs
Number of subjects: 60
Study 28489798 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional microarray of microneedles plus topical 0.5% tranexamic acid solution
Number of subjects: 30
Study 28489798 — intervention group
Group type: COMPARATOR
Intervention: Sham device plus topical 0.5% tranexamic acid solution
Number of subjects: 30
Study 26188890 — intervention group
Group type: EXPERIMENTAL
Intervention: HAM preserved in glycerol 98%
Number of subjects: 40
Study 26188890 — intervention group
Group type: COMPARATOR
Intervention: Vaseline gauze
Number of subjects: 40
Study 24495682 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal injection group, administered via bilateral forearm intradermal injections for immunotherapy once every 21 days, measured after 2, 3, 4, and 5 times of injections.
Number of subjects: 326
Study 24495682 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous injection group, administered via subcutaneous injection once every 21 days, measured after 3 times.
Number of subjects: 326
Study 24495682 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups after blocking antibody turning positive.
Number of subjects: 326
Study 21161814 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational flyer
Number of subjects: 411
Study 21161814 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (posttest only)
Number of subjects: 411
Study 19205272 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 microg initial dose followed by up to 1200 microg if needed)
Number of subjects: 60
Study 19205272 — intervention group
Group type: COMPARATOR
Intervention: Oral misoprostol (400 microg initial dose followed by up to 1200 microg if needed)
Number of subjects: 60
Study 17042841 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior jaw lift manoeuvre
Number of subjects: 50
Study 17042841 — intervention group
Group type: COMPARATOR
Intervention: Berman airway
Number of subjects: 50
Study 14558631 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic diary for home monitoring
Number of subjects: 119
Study 14558631 — intervention group
Group type: COMPARATOR
Intervention: Standard telephone reporting procedures
Number of subjects: 119
Study 11015982 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon sampler
Number of subjects: 62
Study 11015982 — intervention group
Group type: EXPERIMENTAL
Intervention: Sponge sampler
Number of subjects: 62
Study 11015982 — intervention group
Group type: EXPERIMENTAL
Intervention: Sponge-mesh sampler
Number of subjects: 62
Study 11015982 — intervention group
Group type: EXPERIMENTAL
Intervention: All three samplers
Number of subjects: 62
Study 11015982 — intervention group
Group type: EXPERIMENTAL
Intervention: Encapsulated samplers (sponge and sponge-mesh)
Number of subjects: 62
Study 8714631 — intervention group
Group type: EXPERIMENTAL
Intervention: Illusory contours defined by orthogonal lines with a clear gap or overlap
Number of subjects: 0
Study 8714631 — intervention group
Group type: EXPERIMENTAL
Intervention: Illusory contours made up of abutting lines without gap or overlap
Number of subjects: 0
Study 8714631 — intervention group
Group type: EXPERIMENTAL
Intervention: Disparity in illusory borders
Number of subjects: 0
Study 8714631 — intervention group
Group type: EXPERIMENTAL
Intervention: Contours with uniform space-averaged luminance
Number of subjects: 0
Study 1433118 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime (CAZ) monotherapy
Number of subjects: 471
Study 1433118 — intervention group
Group type: COMPARATOR
Intervention: Aminoglycoside+(ureido)penicillin combination (AG+PEN)
Number of subjects: 471
Study 3894199 — intervention group
Group type: COMPARATOR
Intervention: Sengstaken‐Blakemore tube
Number of subjects: 43
Study 3894199 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sclerosis
Number of subjects: 43
Study 29779672 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (measured by body mass index)
Number of subjects: 149683
Study 29779672 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 149683
Study 29779672 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking (in pack‐years)
Number of subjects: 149683
Study 29779672 — intervention group
Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 149683
Study 29779672 — intervention group
Group type: EXPERIMENTAL
Intervention: Age (nonmodifiable risk factor)
Number of subjects: 149683
Study 27815185 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileostomy reversal
Number of subjects: 118
Study 25305763 — intervention group
Group type: COMPARATOR
Intervention: Pulsed Dye Laser (PDL)
Number of subjects: 19
Study 25305763 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) plus topical propranolol
Number of subjects: 19
Study 22266107 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT)
Number of subjects: 18
Study 22266107 — intervention group
Group type: COMPARATOR
Intervention: Non-contact control group
Number of subjects: 18
Study 20832381 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium phosphate wedge (BMCaPh group)
Number of subjects: 40
Study 20832381 — intervention group
Group type: COMPARATOR
Intervention: Autologous tricortical graft (AUTO group)
Number of subjects: 40
Study 17710719 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight road
Number of subjects: 26
Study 17710719 — intervention group
Group type: EXPERIMENTAL
Intervention: Winding road
Number of subjects: 26
Study 17710719 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed route
Number of subjects: 26
Study 15834546 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency-modulated electromagnetic neural stimulation (FREMS)
Number of subjects: 31
Study 15834546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 11932272 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized E2 (2 mg/d) plus standard-dose alendronate (10 mg/d)
Number of subjects: 150
Study 11932272 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized E2 plus low-dose alendronate (5 mg/d)
Number of subjects: 150
Study 11932272 — intervention group
Group type: COMPARATOR
Intervention: Micronized E2 plus placebo (one tablet per day)
Number of subjects: 150
Study 10374427 — intervention group
Group type: EXPERIMENTAL
Intervention: HpPro 7.5 mg orally three times daily
Number of subjects: 20
Study 10374427 — intervention group
Group type: COMPARATOR
Intervention: Mixture of known drugs (control)
Number of subjects: 20
Study 7638426 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching approach of one hour on the respiratory physiology of the CHS and on breathing techniques; n = 5
Number of subjects: 18
Study 7638426 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching approach with breathing retraining of 8 sessions; n = 8
Number of subjects: 18
Study 7638426 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching approach with breathing retraining of 8 sessions and modified Jacobson's progressive relaxation; n = 5
Number of subjects: 18
Study 2696324 — intervention group
Group type: EXPERIMENTAL
Intervention: Hinged cast-brace
Number of subjects: 32
Study 2696324 — intervention group
Group type: COMPARATOR
Intervention: Cylinder plaster cast
Number of subjects: 32
Study 50681 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental gamma-globulin administered at a dose of 3 ml
Number of subjects: 32120
Study 50681 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32120
Study 31533256 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri-Score (NS)
Number of subjects: 154
Study 31533256 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights (MTL)
Number of subjects: 154
Study 31533256 — intervention group
Group type: COMPARATOR
Intervention: Control (no label)
Number of subjects: 154
Study 27272538 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST-IT)
Number of subjects: 39
Study 27272538 — intervention group
Group type: COMPARATOR
Intervention: Active control group (alternative general activities)
Number of subjects: 39
Study 25728933 — intervention group
Group type: EXPERIMENTAL
Intervention: 4F-PCC
Number of subjects: 181
Study 25728933 — intervention group
Group type: COMPARATOR
Intervention: Plasma
Number of subjects: 181
Study 22496329 — intervention group
Group type: EXPERIMENTAL
Intervention: OC000459 (200 mg twice daily)
Number of subjects: 16
Study 22496329 — intervention group
Group type: EXPERIMENTAL
Intervention: OC000459
Number of subjects: 16
Study 21600524 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean-style low-glycemic-load diet plus medical food (phytosterols, soy protein, hops and acacia extracts)
Number of subjects: 89
Study 21600524 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean-style low-glycemic-load diet (control arm)
Number of subjects: 89
Study 21600524 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical food intake (part of intervention)
Number of subjects: 89
Study 19476729 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 27
Study 19476729 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 27
Study 16882708 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/m2 intravenously daily for 5 days
Number of subjects: 95
Study 16882708 — intervention group
Group type: COMPARATOR
Intervention: 20 mg/m2 subcutaneously daily for 5 days
Number of subjects: 95
Study 16882708 — intervention group
Group type: COMPARATOR
Intervention: 10 mg/m2 intravenously daily for 10 days
Number of subjects: 95
Study 16882708 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day intravenous schedule
Number of subjects: 95
Study 17147754 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic randomised controlled trials
Number of subjects: 0
Study 11288772 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion sustained release (SR)
Number of subjects: 24
Study 9449019 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.45 g/lbw
Number of subjects: 11
Study 9449019 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.15 g/lbw
Number of subjects: 11
Study 9449019 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.30 g/lbw
Number of subjects: 11
Study 9449019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 8198936 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril 10 mg
Number of subjects: 253
Study 8198936 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril 20 mg
Number of subjects: 253
Study 8198936 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril 40 mg
Number of subjects: 253
Study 8198936 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril 2.5 mg
Number of subjects: 253
Study 8198936 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril 5 mg
Number of subjects: 253
Study 8198936 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study 3122546 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (up to 320 mg per day)
Number of subjects: 15
Study 3122546 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (up to 120 mg per day)
Number of subjects: 15
Study 3122546 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol or Nifedipine
Number of subjects: 15
Study 3122546 — intervention group
Group type: COMPARATOR
Intervention: Sublingual nitroglycerin therapy (control)
Number of subjects: 15
Study 28830699 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple dietary advice using a uniform pamphlet
Number of subjects: 70
Study 28830699 — intervention group
Group type: COMPARATOR
Intervention: Denture care advice (Control)
Number of subjects: 70
Study 27334070 — intervention group
Group type: EXPERIMENTAL
Intervention: 2800 IU of vitamin D per day for 8 weeks
Number of subjects: 200
Study 27334070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 24705022 — intervention group
Group type: EXPERIMENTAL
Intervention: ALICE app for 3 months
Number of subjects: 99
Study 24705022 — intervention group
Group type: EXPERIMENTAL
Intervention: ALICE app for patients with initially higher rate of medication errors
Number of subjects: 99
Study 24705022 — intervention group
Group type: EXPERIMENTAL
Intervention: ALICE app for patients with no experience with information and communication technologies
Number of subjects: 99
Study 24705022 — intervention group
Group type: EXPERIMENTAL
Intervention: ALICE app satisfaction
Number of subjects: 99
Study 24705022 — intervention group
Group type: EXPERIMENTAL
Intervention: ALICE app perceived independence
Number of subjects: 99
Study 24705022 — intervention group
Group type: COMPARATOR
Intervention: Control group (oral and written information on safe medication use)
Number of subjects: 99
Study 22579007 — intervention group
Group type: EXPERIMENTAL
Intervention: AMC/DCBA + lidocaine lozenge
Number of subjects: 190
Study 22579007 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexylresorcinol lozenge
Number of subjects: 190
Study 22579007 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenge
Number of subjects: 190
Study 20190840 — intervention group
Group type: EXPERIMENTAL
Intervention: liposomal amphotericin B
Number of subjects: 99
Study 20190840 — intervention group
Group type: COMPARATOR
Intervention: no intervention
Number of subjects: 99
Study 20190840 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR tests for Aspergillus after day 100
Number of subjects: 99
Study 18932286 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) therapy combined with Western medicine
Number of subjects: 145
Study 18932286 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 145
Study 16211732 — intervention group
Group type: COMPARATOR
Intervention: succinylcholine 1.0 mg kg[‐1]
Number of subjects: 222
Study 16211732 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.6 mg kg[‐1]
Number of subjects: 222
Study 11930969 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (social skills and anger-control training, academic tutoring, parent training, home visiting)
Number of subjects: 891
Study 11930969 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 891
Study 11930969 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 891
Study 10818662 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of male partners of women with bacterial vaginosis
Number of subjects: 0
Study 7722117 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure
Number of subjects: 0
Study 7722117 — intervention group
Group type: EXPERIMENTAL
Intervention: Ejection fraction
Number of subjects: 0
Study 7722117 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure and ejection fraction
Number of subjects: 0
Study 1961650 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified grid laser photocoagulation
Number of subjects: 185
Study 7049512 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicycle exercise
Number of subjects: 0
Study 7049512 — intervention group
Group type: COMPARATOR
Intervention: Control study (non-exercise)
Number of subjects: 0
Study 31675385 — intervention group
Group type: EXPERIMENTAL
Intervention: Probable UTI (n = 13 participants)
Number of subjects: 1061
Study 31675385 — intervention group
Group type: COMPARATOR
Intervention: Normal urinalysis (n = 387 participants)
Number of subjects: 1061
Study 30085148 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsychosocial prevention course (11 classes on body posture and psychosocial aspects)
Number of subjects: 170
Study 30085148 — intervention group
Group type: COMPARATOR
Intervention: Physical activity promotion (5 classes according to national guidelines)
Number of subjects: 170
Study 26785637 — intervention group
Group type: EXPERIMENTAL
Intervention: TXT2BFiT program (multi-component lifestyle program)
Number of subjects: 214
Study 26785637 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching calls, text messages, emails
Number of subjects: 214
Study 26785637 — intervention group
Group type: EXPERIMENTAL
Intervention: Website and app
Number of subjects: 214
Study 26785637 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall program components
Number of subjects: 214
Study 26785637 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention follow-up
Number of subjects: 214
Study 24664539 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine (4%) pretreatment
Number of subjects: 122
Study 24664539 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tramadol (50-mg) pretreatment
Number of subjects: 122
Study 24664539 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 122
Study 22620493 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate low vision rehabilitation intervention (1-2 weeks after enrollment)
Number of subjects: 100
Study 22620493 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention (control) (3 months after enrollment)
Number of subjects: 100
Study 19072827 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV796 (a selective nonstructural protein 5B polymerase inhibitor)
Number of subjects: 0
Study 19072827 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV796 monotherapy
Number of subjects: 0
Study 19072827 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV796 in combination with interferon (30 mg/kg three times per day)
Number of subjects: 0
Study 19072827 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV796 in combination with pegylated interferon and ribavirin
Number of subjects: 0
Study 19072827 — intervention group
Group type: EXPERIMENTAL
Intervention: HCV796
Number of subjects: 0
Study 17393073 — intervention group
Group type: EXPERIMENTAL
Intervention: Triapine® (96 mg/m2 2‐h infusion daily for 4 days, repeated every 2 weeks)
Number of subjects: 19
Study 17393073 — intervention group
Group type: EXPERIMENTAL
Intervention: Triapine®
Number of subjects: 19
Study 16531503 — intervention group
Group type: EXPERIMENTAL
Intervention: Random group condition with Chips
Number of subjects: 1486
Study 16531503 — intervention group
Group type: EXPERIMENTAL
Intervention: Network condition with Chips
Number of subjects: 1486
Study 16531503 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher condition with Chips
Number of subjects: 1486
Study 16531503 — intervention group
Group type: EXPERIMENTAL
Intervention: Random group condition with Flavor
Number of subjects: 1486
Study 16531503 — intervention group
Group type: EXPERIMENTAL
Intervention: Network condition with Flavor
Number of subjects: 1486
Study 16531503 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher condition with Flavor
Number of subjects: 1486
Study 16531503 — intervention group
Group type: COMPARATOR
Intervention: Curriculum and assignment methods
Number of subjects: 1486
Study 12825566 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg oxycodone
Number of subjects: 0
Study 11036451 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin V
Number of subjects: 133
Study 11036451 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 8634808 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% glycolic acid peels
Number of subjects: 12
Study 8634808 — intervention group
Group type: COMPARATOR
Intervention: 10% glycolic acid-based moisturizer (twice daily)
Number of subjects: 12
Study 1626678 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anaesthesia with oxybuprocaine 0.4%
Number of subjects: 0
Study 1626678 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 0
Study 6196841 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (Claforan) given peroperatively and daily for five days
Number of subjects: 42